ArticleThe oncologist2026

Neoadjuvant intent anti-programmed death-1 immunotherapy for cutaneous squamous cell carcinoma in patients with hematologic malignancy.

Kyle Murchison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.